Yoshinori Onuki

Dr. Yoshinori Onuki


Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2019 in Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
KOKotaro Okada
Kotaro Okada
DHDaijiro Hirai
Daijiro Hirai
SKShungo Kumada
Shungo Kumada
AKAtsushi Kosugi
Atsushi Kosugi
YHYoshihiro Hayashi
Yoshihiro Hayashi
YOYoshinori Onuki
Yoshinori Onuki

1 November 2020 in European Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
KOKousuke Ougi
Kousuke Ougi
KOKotaro Okada
Kotaro Okada
KLKok Hoong Leong
Kok Hoong Leong
YHYoshihiro Hayashi
Yoshihiro Hayashi
SKShungo Kumada
Shungo Kumada
YOYoshinori Onuki
Yoshinori Onuki

1 March 2020 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
TOTakuya Oishi
Takuya Oishi
YHYoshihiro Hayashi
Yoshihiro Hayashi
MNMiho Noguchi
Miho Noguchi
FYFumiaki Yano
Fumiaki Yano
SKShungo Kumada
Shungo Kumada
YOYoshinori Onuki
Yoshinori Onuki

1 August 2020 in Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
AKAtsushi Kosugi
Atsushi Kosugi
KLKok Hoong Leong
Kok Hoong Leong
HTHinako Tsuji
Hinako Tsuji
YHYoshihiro Hayashi
Yoshihiro Hayashi
SKShungo Kumada
Shungo Kumada
YOYoshinori Onuki
Yoshinori Onuki

1 January 2015 in Chemical and Pharmaceutical Bulletin
Verified
Journal Article
Open access
YOYoshinori Onuki
Yoshinori Onuki
CFChiaki Funatani
Chiaki Funatani
TYTakashi Yokawa
Takashi Yokawa
Yoshihisa YamamotoYoshihisa Yamamoto
Yoshihisa Yamamoto
Toshiro FukamiToshiro Fukami
Toshiro Fukami
KTKozo Takayama
Kozo Takayama
A mixed preparation consisting of a water-in-oil emulsion-type moisturizing cream and a steroid ointment is frequently prescribed for the treatment of atopic dermatitis. We have investigated the compatibility of moisturizing creams and ointments because there are concerns regarding the physical stability of these mixed preparations. The key technology used in this study was magnetic resonance imaging (MRI). A commercial moisturizing cream and white petrolatum or clobetasone butyrate (CLB) ointment samples were mixed in a weight ratio of 1 : 1. A centrifugation test protocol (20000×g for 3 min) was implemented to accelerate the destabilization processes in the samples. After centrifugation, the mixed preparations separated into three distinct layers (upper, middle, and lower), while no phase separation was observed using moisturizing cream alone. The phase separation was monitored using chemical shift selective images of water and oil and quantitative T2 maps. In addition, MR and near-infrared spectroscopy were employed for component analysis of each phase-separated layer. Collectively, it was confirmed that the lower layer contained water, oils, and organic solvent, while the upper and middle layers were composed solely of oils. Furthermore, this study investigated the distribution of CLB in the phase-separated samples and showed that a heterogeneous distribution existed. From our results, it was confirmed that the mixed preparation became unstable because of the incompatibility of the moisturizing cream and ointment.

1 October 2019 in Chemical and Pharmaceutical Bulletin
Verified
Journal Article
Closed access
PDF file
KTKeisuke Takagaki
Keisuke Takagaki
TITerushi Ito
Terushi Ito
HAHiroaki Arai
Hiroaki Arai
YOYasuko Obata
Yasuko Obata
KTKozo Takayama
Kozo Takayama
YOYoshinori Onuki
Yoshinori Onuki
Definitive screening design (DSD) is a new class of small three-level experimental design that is attracting much attention as a technical tool of a quality by design (QbD) approach. The purpose of this study is to examine the usefulness of DSD for QbD through a pharmaceutical study on the preparation of ethenzamide-containing orally disintegrating tablet. Model tablets were prepared by directly compressing the mixture of the active pharmaceutical ingredient (API) and excipients. The five evaluated factors assigned to DSD were: the contents of API (X1) and lubricant (X2), and the compression force (X3) of the tableting process, the mixing time (X4), and the filling ratio of powder in the V-type mixer (X5). After tablet preparation, hardness and disintegration time were measured. The same experiments were performed by using the conventional design of experiments [i.e., L8 and L16 orthogonal array designs and central composite design (CCD)]. Results showed that DSD successfully clarified how various factors contribute to tablet properties. Moreover, the analysis result from DSD agreed well with those from the L8 and L16 experiments. In additional experiments, response surfaces for tablet properties were created by DSD. Compared with the response surfaces created by CCD, DSD could produce reliable response surfaces for its smaller number of experiments. We conclude that DSD is a powerful tool for implementing pharmaceutical studies including the QbD approach.